Page last updated: 2024-08-23

etoposide and Cancer of Cervix

etoposide has been researched along with Cancer of Cervix in 114 studies

Research

Studies (114)

Timeframe	Studies, this research(%)	All Research%
pre-1990	9 (7.89)	18.7374
1990's	35 (30.70)	18.2507
2000's	30 (26.32)	29.6817
2010's	34 (29.82)	24.3611
2020's	6 (5.26)	2.80

Authors

Authors	Studies
Jeong, YT; Kim, SK; Pallela, R; Park, DH; Parthiban, P	1
Kruakaew, S; Lhinhatrakool, T; Piyaviriyakul, S; Seeka, C; Siripong, P; Sutthivaiyakit, S; Thongnest, S; Yahuafai, J	1
Lai, CH; Liu, FY; Tung, HJ; Wang, CC	1
An, J; Huang, M; Huang, Y; Li, C; Li, L; Luo, S; Peng, Y; Wang, J; Wang, Z; Wu, L; Yang, H; Yang, X; Zhang, Y	1
Chopra, M; Kaur, S; Rajoria, P	1
Kimura, T; Kurita, T; Miyoshi, AI; Ueda, Y; Yoshino, K	1
Bhosale, P; Chisholm, GB; Flores Legarreta, A; Frumovitz, M; Gonzales, NR; Jhingran, A; Ramalingam, P; Saab, R; Salvo, G	1
Chargari, C; Escande, A; Espenel, S; Morcet-Delattre, R; Tas, P	1
Chang, KM; Chang, SJ; Chen, TC; Chen, YT; Chuang, YJ; Lai, ZY; Yeo, HY	1
Cheng, YM; Chiang, CT; Chou, CY; Huang, YF; New, GH; Tsai, HW; Wu, PY	1
Cheng, Y; He, T; Pei, X; Wu, X; Xiang, L; Yang, H; Yang, W; Ye, S	1
Choi, KH; Hur, SY; Kim, JY; Kim, YS; Lee, DS; Lee, SW; Lee, YH; Park, HH; Park, JS; Sung, S; Yoon, SC	1
Ben Mrad, M; Chauleur, C; de Laroche, G; Espenel, S; Garcia, MA; Guy, JB; Langrand-Escure, J; Magné, N; Moreno-Acosta, P; Rancoule, C; Trone, JC; Vallard, A	1
Hwang, J; Kim, DW; Lee, EJ	1
Bjerke, GA; Muhlrad, D; Parker, R; Shukla, S; Yi, R	1
Anderson, RA; Li, W	1
Lee, DW; Lee, HN; Lee, JW; Lee, KH; Park, JS; Park, ST	1
Cheng, XL; Huang, L; Liao, LM; Lin, JX; Liu, AW; Wu, JB; Zheng, M	1
Bellefqih, S; Benjaafar, N; Kebdani, T; Khalil, J; Mezouri, I	1
Kadalayil, L; KhoshZaban, M; Kuku, S; Ledermann, J; Loddo, M; McCormack, M; Proctor, I	1
Du, XL; Li, HQ; Lu, CH; Pan, CX; Sheng, XG; Wang, C; Yin, YJ	1
Bae, J; Jin, H; Kim, TH; Lee, K; Suh, DS; Yeom, JH	1
Fang, J; Liu, LF; Wu, MJ; Yin, ZM; Yu, AJ; Yu, H; Zhu, JQ	1
Armato, U; Chiarini, A; Dal Prà, I; Liu, D	1
Bhattacharya, S; Maiti, A	1
Bohle, RM; Büttner, R; Fischbach, J; Horn, LC; Juhasz-Böss, I; Kim, YJ; Mallmann, P; Pahne-Zeppenfeld, J; Rübe, C; Smola, S; Solomayer, EF; Stern, P; Ströder, R; Tharun, L; Walch-Rückheim, B; Wickenhauser, C	1
Algren, SD; Dziadek, OL; Ruiz, MP	1
Bae, JH; Bae, SN; Lee, A; Lee, SJ; Namkoong, SE; Park, JS; Park, YG	1
Nagai, T; Okubo, T; Sakaguchi, R; Seki, H; Takeda, S	1
Abu-Rustum, NR; Aghajanian, C; Alektiar, K; Chi, DS; Diaz, JP; Konner, J; Leitao, MM; Park, KJ; Zhao, H; Zivanovic, O	1
Chan, MY; Leung, CW; Li, WW; Pong, WM; Yau, TN	1
Bhattacharya, RK; Dey, S; Mukherjee, S; Roy, M	1
Gouliamos, A; Koukourakis, GV; Kouloulias, V; Maravelis, G; Papadimitriou, C; Platoni, K; Zacharias, G	1
Guo, LN; Han, XY; Huang, HF; Pan, LY; Sheng, K; Wan, XR; Xiang, Y	1
Chan, JK; Chen, LM; Cohen, JG; Kapp, DS; Osann, K; Sherman, AE; Shin, JY; Urban, R	1
Donaldson, MM; Dornan, ES; Fisk, JC; King, LE; Melendy, T; Morgan, IM	1
Bae, SN; Chun, SH; Hong, SH; Hur, SY; Jeon, EK; Lee, A; Lee, KH; Park, JS; Won, HS; Yoon, SC	1
Lee, DW; Lee, HN; Lee, KH; Lee, YS; Park, EK; Park, JS	1
Futagami, M; Mizunuma, H; Yokoyama, Y	1
Hatae, M; Hoshiai, H; Isaka, K; Kamiura, S; Kawamura, N; Nakanishi, T; Ochiai, K; Ohmichi, M; Tanaka, N; Watanabe, Y	1
Bouvy, JJ; Braun, JJ; Ruit, JB	1
Guo, N; Lou, J; Peng, Z; Yang, K	1
Hai-Yan, S; Jian-Qing, Z; Lan-Fang, L; Ya-Qing, C; Zuo-Ming, Y	1
Armato, U; Chiarini, A; Dal Prà, I; Marconi, M; Pacchiana, R; Wu, J	1
Bian, ML; Higuma, C; Isaka, K; Ito, H; Liang, J; Nishi, H; Sasaki, T	1
Ito, K; Kaiho-Sakuma, M; Kurosawa, H; Nagai, T; Nagase, S; Niikura, H; Otsuki, T; Takano, T; Tanaka, S; Tokunaga, H; Toyoshima, M; Utsunomiya, H; Yaegashi, N; Yoshinaga, K	1
Blessing, JA; Buller, RE; Mannel, RS; Rose, PG; Webster, KD	1
Aquino-Parsons, C; Hoskins, PJ; Lee, N; Lim, P; Pike, JA; Swenerton, KD; Wong, F	1
Fiorica, JV	1
HELD, F; SCHWARZ, R	1
Hoshino, H; Saitoh, K; Seki, H; Sodemoto, T; Takada, T; Uekusa, T	1
Ivanov, S; Zervoudis, S	1
Nishiura, K; Obata, H; Okugawa, T; Tabata, T; Tanaka, K; Toyoda, N; Yanoh, K	1
Linghu, H; Mei, YY; Sun, T; Tang, JY; Tang, LD; Xu, XR	1
Banáth, JP; Olive, PL; Sinnott, LT	1
Hara, K; Iwasaka, T	1
Al, A; Baykal, C; Bulbul, D; Güler, G; Küçükali, T; Ozer, S; Tulunay, G	1
Scorilas, A; Thomadaki, H; Tsiapalis, CM	1
Burger, CW; Ewing, P; Seynaeve, C; Snijders-Keilholz, A	1
Bai, T; Tanaka, T; Umesaki, N; Yukawa, K	1
Kroemer, G; Larochette, N; Massard, C; Métivier, D; Pauleau, AL; Sabatier, L; Soria, JC; Zermati, Y	1
Feng, YL; Li, JD; Li, MD; Liu, JH; Shi, HL; Xiao, Y	1
Kim, JJ; Lee, SB; Park, JS; Tong, SY; Um, SJ	1
Blessing, JA; Homesley, HD; Slayton, RE	1
Charrot-Chinet, P; Chauvergne, J; Héron, JF; Mayer, F; Toulouse, C	1
Ho, ES; Hsu, WP; Jan, JS; Lin, JC; Yang, CH	1
Banáth, JP; Fjell, CD; Olive, PL	1
Hayakawa, O; Kudo, R; Takehara, M	1
Hoshino, K; Mitsuya, T; Morioka, M; Noguchi, Y; Notake, Y; Okuyama, D; Shimizu, A; Takahashi, J; Watanabe, S; Yoda, A	1
Baillet, F; Delanian, S; Housset, M; Lecuru, F; Maulard-Durdux, C; Taurelle, R	1
Hara, K; Iwasaka, T; Matsuo, N; Mvula, M; Nakao, Y; Sugimori, H; Yamasaki, F; Yokoyama, M	1
Neijt, JP	1
Acker, B; Hoskins, PJ; Le Riche, J; Manji, M; McMurtrie, E; Pike, JA; Swenerton, KD; Wong, F	1
Cimoli, G; Conte, P; Mariani, GL; Parodi, S; Russo, P; Valenti, M; Venturini, M	1
Ho, ES; Jan, JS; Lin, JC; Liu, FS; Yang, CH	1
Clynes, M; Dolan, E; Heenan, M; Kavanagh, K; Maher, M; Moriarty, M; O'Neill, P; Redmond, A	1
Hayashi, N; Ikeba, K; Kinoshita, K; Ohokubo, T; Sodemoto, T; Takagi, A; Takeda, S; Yamamoto, T	1
Al-Saleh, E; Hoskins, PJ; Pike, JA; Swenerton, KD	1
Ikeba, K; Kimura, M; Kinoshita, K; Maeda, H; Ohkubo, T; Sodemoto, T; Suwata, J; Suzuki, Y; Takagi, A; Takeda, S; Yamamoto, T	1
Bishop, JF; Millward, MJ; Quinn, M; Rischin, D; Rome, R; Tebbutt, N; Toner, GC	1
Chang, L; Ogita, S; Tanaka, T; Umesaki, N	1
Beppu, M; Chiba, T; Hiura, M; Kawakami, Y; Nogawa, T; Yokoyama, T	1
Chang, TC; Chou, HH; Hsueh, S; Huang, KG; Lai, CH; Tseng, CJ	1
Brader, KR; Burke, TW; Gershenson, DM; Levenback, CF; Morris, M	1
Fukuda, K; Hara, K; Iwasaka, T; Nakao, Y; Sugimori, H; Uchiyama, M; Yokoyama, M	1
Blessing, JA; Rose, PG; Van Le, L; Waggoner, S	1
Fujii, S; Hasegawa, K; Hirabayasi, K; Ikeda, M; Izumi, R; Kono, I; Kudo, R; Niitani, H; Nishiya, I; Noda, K; Ochiai, K; Ogita, Y; Okada, H; Ozaki, M; Saito, T; Sugimori, H; Suzuoki, Y; Tanaka, K; Terashima, Y; Tomoda, Y; Umesaki, N; Yajima, A; Yakushiji, M; Yamabe, T; Yamamoto, T	1
Hatae, M; Hiura, M; Hoshiai, H; Ikeda, M; Izumi, R; Noda, K; Ogita, Y; Okada, H; Ozaki, M; Ozawa, M; Tamaya, T; Tanaka, K; Yamabe, T	1
Chao, HT; Chiang, H; Lai, CR; Lee, SD; Lee, WL; Ng, HT; Tseng, JY; Wang, PH; Yuan, CC	1
Leung, TW; Lo, SH; O, SK; Sze, WK; Tung, SY; Wong, FC; Wong, SF; Yuen, MK	1
Fushiki, H; Hasegawa, K; Izumi, R; Kono, I; Nishida, M; Noda, K; Noguchi, H; Okuda, H; Sugimori, H; Takizawa, K; Tanaka, T; Udagawa, Y; Umesaki, N; Yamamoto, K	1
Fujita, T; Hayashi, T; Higashihara, J; Irie, T; Ohishi, Y; Shigematsu, T	1
Banáth, JP; Johnston, PJ; MacPhail, SH; Olive, PL; Oloumi, A	1
Angelelli, B; Bovicelli, A; Ceccarelli, C; Costa, S; Erzén, M; Lipponen, P; Martoni, A; Santini, D; Syrjänen, K; Syrjänen, S; Terzano, P	1
Amo-Takyi, BK; Boabang, P; Kohlhagen, H; Kurbacher, CM; Waida, A	1
Artusi, T; Bonacorsi, G; Longo, L; Rivasi, F; Rossi, G	1
Boruta, DM; Castrillon, DH; Crum, CP; Duska, LA; Schorge, JO; Sheets, EE	1
Khanna, N; Reddy, VG; Singh, N	1
Dalrymple, C; Firth, I; MacLeod, C; O'Donnell, A; Tattersall, MH	1
Alftan, H; Lehtovirta, P; Leminen, A; Stenman, UH	1
Burke, TW; Eifel, P; Gershenson, DM; Mitchell, MF; Morris, M; Silva, EG; Wharton, JT	1
Chang, TC; Hsu, JJ; Hsueh, S; Soong, YK	1
Fushiki, H	1
Ehrlich, L; Goldberg, GL; Jones, JG; O'Hanlan, KA; Rodriguez-Rodriguez, L; Runowicz, CD	1
Kredentser, DC	1
Ishii, S; Itoh, O; Kariya, Y; Kawaharajo, K; Nagasawa, M; Takeuchi, T; Yamamoto, H	1
Eiermann, W; Fateh-Moghadam, A; Hepp, H; Meier, W; Schneider, A; Stieber, P	1
Kelland, LR; Steel, GG; Tonkin, KS	1
Kelland, LR; Tonkin, KS	1
Coffman, FD; Godwin, A; Green, LM; Ware, CF	1
Eiermann, W; Fateh-Moghadam, A; Hepp, H; Meier, W; Stieber, P	1
Kawashima, Y; Kobayashi, H	1
Kubo, H; Maeda, T; Okamura, S; Sano, T; Sugimoto, O; Ueda, M; Ueki, M; Yamada, T	1
Grönroos, M; Kangas, L; Mäenpää, J	1

Reviews

11 review(s) available for etoposide and Cancer of Cervix

Article	Year
Recent Advances in the Management of Small Cell Carcinoma of the Uterine Cervix. Anticancer research, 2023, Volume: 43, Issue:4 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Neuroendocrine; Carcinoma, Small Cell; Cervix Uteri; Cisplatin; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Neoplasm Staging; Platinum; Rare Diseases; Small Cell Lung Carcinoma; Uterine Cervical Neoplasms	2023
Role of radiotherapy in the management of rare gynaecological cancers. Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique, 2023, Volume: 27, Issue:8 Topics: Brachytherapy; Carcinoma, Neuroendocrine; Etoposide; Female; Humans; Retrospective Studies; Uterine Cervical Neoplasms	2023
[Small cell neuroendocrine carcinoma of the uterine cervix: Report of six cases and a review of the literature]. Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique, 2014, Volume: 18, Issue:3 Topics: Adult; Antineoplastic Agents; Carcinoma, Neuroendocrine; Carcinoma, Small Cell; Chemotherapy, Adjuvant; Cisplatin; Etoposide; Female; Humans; Hysterectomy; Lymph Node Excision; Middle Aged; Neoplasm Metastasis; Radiotherapy, Adjuvant; Retrospective Studies; Uterine Cervical Neoplasms	2014
Embryonal rhabdomyosarcoma of the uterine cervix. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2009, Volume: 11, Issue:6 Topics: Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Diagnostic Errors; Etoposide; Female; Humans; Hysterectomy; Ifosfamide; Lymph Node Excision; Ovariectomy; Particle Accelerators; Photons; Polyps; Radiotherapy, Adjuvant; Radiotherapy, Conformal; Remission Induction; Rhabdomyosarcoma, Embryonal; Uterine Cervical Neoplasms; Uterine Hemorrhage; Young Adult	2009
Small cell carcinoma of the cervix: treatment and survival outcomes of 188 patients. American journal of obstetrics and gynecology, 2010, Volume: 203, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Small Cell; Chemotherapy, Adjuvant; Cisplatin; Etoposide; Female; Humans; Hysterectomy; Kaplan-Meier Estimate; Lymph Node Excision; Lymphatic Metastasis; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Radiotherapy, Adjuvant; Registries; Uterine Cervical Neoplasms	2010
The role of topotecan in the treatment of advanced cervical cancer. Gynecologic oncology, 2003, Volume: 90, Issue:3 Pt 2 Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials as Topic; Drug Synergism; Etoposide; Female; Humans; Paclitaxel; Topotecan; Uterine Cervical Neoplasms	2003
[Chemotherapy with mitomycin C, etoposide and cisplatin for adenocarcinoma of the uterine cervix]. Nihon rinsho. Japanese journal of clinical medicine, 2004, Volume: 62 Suppl 10 Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Etoposide; Female; Humans; Mitomycin; Neoadjuvant Therapy; Prognosis; Uterine Cervical Neoplasms	2004
Primitive neuroectodermal tumor of the cervix uteri: a case report -- changing concepts in therapy. Gynecologic oncology, 2005, Volume: 98, Issue:3 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Dactinomycin; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Mesna; Neoadjuvant Therapy; Neuroectodermal Tumors, Primitive, Peripheral; Uterine Cervical Neoplasms; Vincristine	2005
Advances in the chemotherapy of gynecologic cancer. Current opinion in oncology, 1994, Volume: 6, Issue:5 Topics: Altretamine; Antineoplastic Agents; Clinical Trials as Topic; Endometrial Neoplasms; Etoposide; Female; Genital Neoplasms, Female; Germinoma; Humans; Ovarian Neoplasms; Pregnancy; Trophoblastic Neoplasms; Uterine Cervical Neoplasms	1994
Multimodality therapy in early-stage neuroendocrine carcinoma of the uterine cervix. Gynecologic oncology, 2001, Volume: 81, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Neuroendocrine; Chemotherapy, Adjuvant; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Hysterectomy; Middle Aged; Neoplasm Staging; Prognosis; Survival Rate; Uterine Cervical Neoplasms; Vincristine	2001
Adjuvant therapy for neuroendocrine small cell carcinoma of the cervix: review of the literature. Gynecologic oncology, 1991, Volume: 43, Issue:2 Topics: Adult; Carcinoma, Small Cell; Chemotherapy, Adjuvant; Cisplatin; Endocrine Gland Neoplasms; Etoposide; Female; Humans; Middle Aged; Nervous System Neoplasms; Uterine Cervical Neoplasms	1991

Trials

20 trial(s) available for etoposide and Cancer of Cervix

Article	Year
Do Cell-Cycle Phase-Specific Markers Predict Disease Grade, Stage, and Outcome in Cervical Carcinoma? International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2015, Volume: 25, Issue:6 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carboplatin; Carcinoma, Squamous Cell; Cell Cycle; Chemoradiotherapy; Cisplatin; Etoposide; Female; Follow-Up Studies; Humans; Immunoenzyme Techniques; Middle Aged; Neoadjuvant Therapy; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasm Staging; Paclitaxel; Prognosis; Survival Rate; Uterine Cervical Neoplasms; Young Adult	2015
Neoadjuvant cisplatin and etoposide followed by radical hysterectomy for stage 1B-2B cervical cancer. Gynecologic oncology, 2008, Volume: 111, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Humans; Hysterectomy; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Uterine Cervical Neoplasms; Young Adult	2008
ERCC1 (excision repair cross-complementation group 1) expression as a predictor for response of neoadjuvant chemotherapy for FIGO stage 2B uterine cervix cancer. Gynecologic oncology, 2011, Volume: 120, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease-Free Survival; DNA Repair; DNA-Binding Proteins; Endonucleases; Etoposide; Female; Humans; Immunohistochemistry; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Predictive Value of Tests; Uterine Cervical Neoplasms	2011
Weekly cisplatin therapy compared with triweekly combination chemotherapy as concurrent adjuvant chemoradiation therapy after radical hysterectomy for cervical cancer. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2011, Volume: 21, Issue:1 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Etoposide; Female; Fluorouracil; Humans; Hysterectomy; Kaplan-Meier Estimate; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Paclitaxel; Proportional Hazards Models; Radiotherapy, Adjuvant; Survival Rate; Uterine Cervical Neoplasms	2011
Small cell carcinoma of the uterine cervix: clinical outcome of concurrent chemoradiotherapy with a multidrug regimen. The Tohoku journal of experimental medicine, 2013, Volume: 229, Issue:1 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Chemoradiotherapy; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Endpoint Determination; Etoposide; Female; Humans; Immunohistochemistry; Kaplan-Meier Estimate; Middle Aged; Neutropenia; Prednisone; Treatment Outcome; Uterine Cervical Neoplasms; Vincristine	2013
Prolonged oral etoposide in recurrent or advanced non-squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study. Gynecologic oncology, 2003, Volume: 89, Issue:2 Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Antineoplastic Agents, Phytogenic; Carcinoma, Adenosquamous; Drug Administration Schedule; Etoposide; Female; Humans; Middle Aged; Uterine Cervical Neoplasms	2003
[Chemotherapy of cancers of the uterine cervix with a combination of bleomycin, mitomycin, cisplatin and etoposide]. Bulletin du cancer, 1993, Volume: 80, Issue:1 Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Cisplatin; Drug Evaluation; Etoposide; Female; Humans; Middle Aged; Mitomycins; Uterine Cervical Neoplasms	1993
Concomitant chemoradiotherapy for advanced epidermoid carcinoma of the uterine cervix: a preliminary report. Zhonghua yi xue za zhi = Chinese medical journal; Free China ed, 1994, Volume: 54, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brachytherapy; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Etoposide; Female; Follow-Up Studies; Humans; Middle Aged; Prospective Studies; Remission Induction; Uterine Cervical Neoplasms	1994
Small cell carcinoma of the cervix treated with concurrent radiotherapy, cisplatin, and etoposide. Gynecologic oncology, 1995, Volume: 56, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Drug Administration Schedule; Etoposide; Female; Humans; Middle Aged; Uterine Cervical Neoplasms	1995
[Clinical effect of intra-arterial carboplatin-combined chemotherapy for advanced uterine cervical cancer and increased tissue platinum levels with Lipo PGE1 administration before chemotherapy]. Gan to kagaku ryoho. Cancer & chemotherapy, 1996, Volume: 23, Issue:12 Topics: Adenocarcinoma; Adult; Aged; Alprostadil; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Carcinoma, Squamous Cell; Cervix Uteri; Chemotherapy, Adjuvant; Epirubicin; Etoposide; Female; Humans; Iliac Artery; Infusions, Intra-Arterial; Infusions, Intravenous; Middle Aged; Mitomycin; Platinum; Uterine Cervical Neoplasms; Vindesine	1996
Cisplatin/etoposide chemotherapy for recurrent or primarily advanced cervical carcinoma. Gynecologic oncology, 1997, Volume: 64, Issue:3 Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Female; Follow-Up Studies; Humans; Middle Aged; Neoplasm Recurrence, Local; Quality of Life; Remission Induction; Survival Rate; Uterine Cervical Neoplasms	1997
A phase II trial of carboplatin and etoposide for relapsed or metastatic carcinoma of the cervix. The Australian & New Zealand journal of obstetrics & gynaecology, 1998, Volume: 38, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Confidence Intervals; Etoposide; Female; Humans; Neoplasm Recurrence, Local; Prospective Studies; Treatment Outcome; Uterine Cervical Neoplasms	1998
Prognostic factors in surgically treated small cell cervical carcinoma followed by adjuvant chemotherapy. Cancer, 1998, Aug-15, Volume: 83, Issue:4 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Small Cell; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Middle Aged; Neoplasm Staging; Prognosis; Prospective Studies; Uterine Cervical Neoplasms; Vinblastine; Vincristine	1998
A phase II study of prolonged oral etoposide in advanced or recurrent carcinoma of the cervix. Gynecologic oncology, 1998, Volume: 70, Issue:2 Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents, Phytogenic; Drug Administration Schedule; Etoposide; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Uterine Cervical Neoplasms	1998
Prolonged oral etoposide in recurrent or advanced squamous cell carcinoma of the cervix: a gynecologic oncology group study. Gynecologic oncology, 1998, Volume: 70, Issue:2 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Carcinoma, Squamous Cell; Etoposide; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Uterine Cervical Neoplasms	1998
[Early phase II trial of oral etoposide administered for 21 consecutive days in patients with cervical or ovarian cancer. ETP 21 Study Group--Cervical-Ovarian Cancer Group]. Gan to kagaku ryoho. Cancer & chemotherapy, 1998, Volume: 25, Issue:13 Topics: Administration, Oral; Adult; Aged; Alopecia; Anorexia; Antineoplastic Agents, Phytogenic; Drug Administration Schedule; Etoposide; Female; Humans; Leukopenia; Middle Aged; Nausea; Neutropenia; Ovarian Neoplasms; Thrombocytopenia; Uterine Cervical Neoplasms	1998
[Late phase II trial of oral etoposide administered for 21 consecutive days in patients with cervical cancer. ETP 21 Study Group--Cervical Cancer Group]. Gan to kagaku ryoho. Cancer & chemotherapy, 1998, Volume: 25, Issue:14 Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Alopecia; Antineoplastic Agents, Phytogenic; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Drug Administration Schedule; Etoposide; Female; Humans; Middle Aged; Nausea; Uterine Cervical Neoplasms; Vomiting	1998
Cervical adenocarcinoma, a novel combination chemotherapy with mitomycin C, etoposide, and cisplatin for advanced or recurrent disease. Gynecologic oncology, 1999, Volume: 75, Issue:1 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease Progression; Etoposide; Female; Humans; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prospective Studies; Uterine Cervical Neoplasms	1999
CD44 isoform 6 (CD44v6) is a prognostic indicator of the response to neoadjuvant chemotherapy in cervical carcinoma. Gynecologic oncology, 2001, Volume: 80, Issue:1 Topics: Adenocarcinoma; Adult; Aged; alpha Catenin; Antineoplastic Combined Chemotherapy Protocols; beta Catenin; Biomarkers, Tumor; Bleomycin; Cadherins; Carcinoma, Adenosquamous; Cisplatin; Cytoskeletal Proteins; Disease-Free Survival; Epirubicin; Etoposide; Female; Glycoproteins; Humans; Hyaluronan Receptors; Hysterectomy; Immunohistochemistry; Middle Aged; Neoadjuvant Therapy; Survival Rate; Trans-Activators; Uterine Cervical Neoplasms	2001
Treatment of small cell carcinoma of the cervix with cisplatin, doxorubicin, and etoposide. Gynecologic oncology, 1992, Volume: 47, Issue:1 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Humans; Hysterectomy; Infusions, Intravenous; Middle Aged; Neoplasm Staging; Prospective Studies; Uterine Cervical Neoplasms	1992

Other Studies

83 other study(ies) available for etoposide and Cancer of Cervix

Article	Year
Synthesis of polyfunctionalized piperidone oxime ethers and their cytotoxicity on HeLa cells. Bioorganic & medicinal chemistry letters, 2011, Nov-15, Volume: 21, Issue:22 Topics: Antineoplastic Agents; Cell Survival; Ethers; Female; HeLa Cells; Humans; Oximes; Piperidones; Structure-Activity Relationship; Uterine Cervical Neoplasms	2011
Cytotoxic Cardiac Glycoside Constituents of Vallaris glabra Leaves. Journal of natural products, 2017, 11-22, Volume: 80, Issue:11 Topics: Antineoplastic Agents, Phytogenic; Apocynaceae; Cardenolides; Cardiac Glycosides; Female; Glycosides; Humans; Inhibitory Concentration 50; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Plant Leaves; Thailand; Uterine Cervical Neoplasms	2017
Complete remission of advanced and recurrent cervical cancer with pembrolizumab treatment- 3 case reports. Taiwanese journal of obstetrics & gynecology, 2021, Volume: 60, Issue:5 Topics: Adult; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cisplatin; Etoposide; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Retrospective Studies; Treatment Outcome; Uterine Cervical Neoplasms	2021
Therapeutic strategy analysis of patients with advanced stage high-grade neuroendocrine cervical cancer: A real-world multicenter study. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2022, Volume: 158, Issue:3 Topics: Carboplatin; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Etoposide; Female; Humans; Neoplasm Staging; Paclitaxel; Retrospective Studies; Treatment Outcome; Uterine Cervical Neoplasms	2022
Ricolinostat suppresses proliferation, promotes apoptosis, and enhances the antiproliferative activity of topoisomerase inhibitors in cervical cancer cells. Drug development research, 2022, Volume: 83, Issue:8 Topics: Apoptosis; Cell Line, Tumor; Cell Proliferation; Etoposide; Female; Humans; Reactive Oxygen Species; Topoisomerase Inhibitors; Topotecan; Uterine Cervical Neoplasms	2022
Clinicopathologic characteristics, oncologic outcomes, and prognostic factors in neuroendocrine cervical carcinoma: a Neuroendocrine Cervical Tumor Registry study. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2023, 09-04, Volume: 33, Issue:9 Topics: Adult; Aged; Aged, 80 and over; Carboplatin; Carcinoma, Neuroendocrine; Cisplatin; Etoposide; Female; Humans; Middle Aged; Neoplasm Staging; Neuroendocrine Tumors; Prognosis; Registries; Retrospective Studies; Uterine Cervical Neoplasms; Young Adult	2023
PI3K inhibitor enhances the cytotoxic response to etoposide and cisplatin in a newly established neuroendocrine cervical carcinoma cell line. Oncotarget, 2017, Jul-11, Volume: 8, Issue:28 Topics: Animals; Antineoplastic Agents; Apoptosis; Biomarkers; Carcinoma, Neuroendocrine; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cisplatin; Disease Models, Animal; DNA Damage; Drug Synergism; Etoposide; Female; Humans; Mice; Papillomavirus Infections; Phosphoinositide-3 Kinase Inhibitors; Uterine Cervical Neoplasms; Xenograft Model Antitumor Assays	2017
Case report: term birth after fertility-sparing treatments for stage IB1 small cell neuroendocrine carcinoma of the cervix. BMC women's health, 2017, 07-28, Volume: 17, Issue:1 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Neuroendocrine; Cisplatin; Etoposide; Female; Fertility; Humans; Ifosfamide; Neoplasm Staging; Pregnancy; Term Birth; Uterine Cervical Neoplasms	2017
Cycles of cisplatin and etoposide affect treatment outcomes in patients with FIGO stage I-II small cell neuroendocrine carcinoma of the cervix. Gynecologic oncology, 2017, Volume: 147, Issue:3 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Neuroendocrine; Carcinoma, Small Cell; Chemotherapy, Adjuvant; Cisplatin; Drug Administration Schedule; Etoposide; Female; Humans; Kaplan-Meier Estimate; Neoplasm Staging; Retrospective Studies; Uterine Cervical Neoplasms	2017
Clinical impact of boost irradiation to pelvic lymph node in uterine cervical cancer treated with definitive chemoradiotherapy. Medicine, 2018, Volume: 97, Issue:16 Topics: Brachytherapy; Chemoradiotherapy; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Etoposide; Female; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Outcome and Process Assessment, Health Care; Pelvis; Radiotherapy Dosage; Republic of Korea; Uterine Cervical Neoplasms	2018
Outcomes and treatments of IB1 cervical cancers with high recurrence risk: A 13 years' experience. Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique, 2018, Volume: 22, Issue:8 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carboplatin; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Etoposide; Female; Humans; Iridium Radioisotopes; Kaplan-Meier Estimate; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Prognosis; Radiotherapy, Adjuvant; Recurrence; Retrospective Studies; Risk; Treatment Outcome; Uterine Cervical Neoplasms	2018
Small-cell neuroendocrine carcinoma of the uterine cervix with pancreatic metastasis: a case report and a review of the literature. Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology, 2019, Volume: 39, Issue:4 Topics: Adult; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Neuroendocrine; Cisplatin; Etoposide; Female; Humans; Neoplasm Invasiveness; Palliative Care; Pancreatic Neoplasms; Uterine Cervical Neoplasms; Whole Body Imaging	2019
The RNase PARN Controls the Levels of Specific miRNAs that Contribute to p53 Regulation. Molecular cell, 2019, 03-21, Volume: 73, Issue:6 Topics: 3' Untranslated Regions; Antineoplastic Agents; Cell Survival; DEAD-box RNA Helicases; Doxorubicin; Etoposide; Exoribonucleases; Female; Gene Expression Regulation, Neoplastic; HCT116 Cells; HeLa Cells; Humans; MicroRNAs; Polyadenylation; Ribonuclease III; Ribonucleases; RNA Nucleotidyltransferases; RNA Stability; Signal Transduction; Tumor Suppressor Protein p53; Uterine Cervical Neoplasms	2019
Star-PAP controls HPV E6 regulation of p53 and sensitizes cells to VP-16. Oncogene, 2014, Feb-13, Volume: 33, Issue:7 Topics: Antineoplastic Agents, Phytogenic; Cell Proliferation; DNA-Binding Proteins; Etoposide; Female; Gene Expression; Gene Expression Regulation, Neoplastic; HeLa Cells; Humans; Nucleotidyltransferases; Oncogene Proteins, Viral; Papillomavirus Infections; Polyadenylation; Polynucleotide Adenylyltransferase; RNA, Messenger; Tumor Suppressor Protein p53; Uterine Cervical Neoplasms	2014
Is neoadjuvant chemotherapy followed by radical surgery more effective than radiation therapy for stage IIB cervical cancer? International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2013, Volume: 23, Issue:7 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Etoposide; Female; Fluorouracil; Follow-Up Studies; Humans; Hysterectomy; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Paclitaxel; Prognosis; Radiotherapy, Adjuvant; Retrospective Studies; Survival Rate; Uterine Cervical Neoplasms	2013
Analysis of the impact of platinum-based combination chemotherapy in small cell cervical carcinoma: a multicenter retrospective study in Chinese patients. BMC cancer, 2014, Feb-27, Volume: 14 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asian People; Carcinoma, Small Cell; Cisplatin; Etoposide; Female; Follow-Up Studies; Humans; Middle Aged; Paclitaxel; Retrospective Studies; Taxoids; Uterine Cervical Neoplasms; Young Adult	2014
The Treatment of Pelvic Locoregional Recurrence of Cervical Cancer After Radical Surgery With Intensity-Modulated Radiation Therapy Compared With Conventional Radiotherapy: A Retrospective Study. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2015, Volume: 25, Issue:6 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brachytherapy; Carboplatin; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Combined Modality Therapy; Etoposide; Female; Follow-Up Studies; Humans; Hysterectomy; Middle Aged; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasm Staging; Paclitaxel; Pelvic Neoplasms; Prognosis; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated; Remission Induction; Retrospective Studies; Survival Rate; Uterine Cervical Neoplasms	2015
IER3 is a crucial mediator of TAp73β-induced apoptosis in cervical cancer and confers etoposide sensitivity. Scientific reports, 2015, Feb-10, Volume: 5 Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Apoptosis Regulatory Proteins; DNA-Binding Proteins; Drug Resistance, Neoplasm; Etoposide; Female; HeLa Cells; Humans; Membrane Proteins; Nuclear Proteins; Tumor Protein p73; Tumor Suppressor Proteins; Uterine Cervical Neoplasms	2015
Effects and toxicity of neoadjuvant chemotherapy preoperative followed by adjuvant chemoradiation in small cell neurdendocrine cervical carcinoma. European journal of gynaecological oncology, 2015, Volume: 36, Issue:3 Topics: Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Neuroendocrine; Carcinoma, Small Cell; Chemoradiotherapy, Adjuvant; Cisplatin; Doxorubicin; Etoposide; Female; Hepatic Insufficiency; Humans; Hysterectomy; Ifosfamide; Middle Aged; Neoadjuvant Therapy; Neutropenia; Paclitaxel; Renal Insufficiency; Thrombocytopenia; Treatment Outcome; Uterine Cervical Neoplasms; Vincristine	2015
Bcl10 crucially nucleates the pro-apoptotic complexes comprising PDK1, PKCζ and caspase-3 at the nuclear envelope of etoposide-treated human cervical carcinoma C4-I cells. International journal of molecular medicine, 2015, Volume: 36, Issue:3 Topics: 3-Phosphoinositide-Dependent Protein Kinases; Adaptor Proteins, Signal Transducing; Antineoplastic Agents, Phytogenic; Apoptosis; B-Cell CLL-Lymphoma 10 Protein; Caspase 3; Cell Line, Tumor; Cervix Uteri; Etoposide; Female; Humans; Nuclear Envelope; Protein Kinase C; Uterine Cervical Neoplasms	2015
A patient with cancer and nail pigmentation. BMJ (Clinical research ed.), 2016, 05-03, Volume: 353 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Black or African American; Cyclophosphamide; Doxorubicin; Etoposide; Febrile Neutropenia; Female; Humans; Lymphoma, B-Cell; Nail Diseases; Nails; Pigmentation Disorders; Prednisone; Uterine Cervical Neoplasms; Vincristine	2016
STAT3/IRF1 Pathway Activation Sensitizes Cervical Cancer Cells to Chemotherapeutic Drugs. Cancer research, 2016, 07-01, Volume: 76, Issue:13 Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Biomarkers, Tumor; Blotting, Western; Cell Proliferation; Cisplatin; Etoposide; Female; Humans; Immunoenzyme Techniques; Interferon Regulatory Factor-1; Neoplasm Staging; Precancerous Conditions; Prognosis; STAT3 Transcription Factor; Tumor Cells, Cultured; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms	2016
Nonsurgical Management of Neuroendocrine Cancer of the Cervix: Brief Report. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2016, Volume: 26, Issue:7 Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Neuroendocrine; Cisplatin; Etoposide; Female; Humans; Middle Aged; Missouri; Retrospective Studies; Uterine Cervical Neoplasms	2016
Glassy cell carcinoma of the uterine cervix responsive to neoadjuvant intraarterial chemotherapy. International journal of clinical oncology, 2008, Volume: 13, Issue:6 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Combined Modality Therapy; Epirubicin; Etoposide; Female; Humans; Hysterectomy; Infusions, Intra-Arterial; Neoadjuvant Therapy; Neoplasm Staging; Treatment Outcome; Uterine Cervical Neoplasms	2008
Small cell neuroendocrine carcinoma of the cervix: Analysis of outcome, recurrence pattern and the impact of platinum-based combination chemotherapy. Gynecologic oncology, 2009, Volume: 112, Issue:3 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Neuroendocrine; Carcinoma, Small Cell; Cisplatin; Etoposide; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Retrospective Studies; Treatment Outcome; Uterine Cervical Neoplasms	2009
Large-cell neuroendocrine carcinoma of the uterine cervix complicating pregnancy. Hong Kong medical journal = Xianggang yi xue za zhi, 2009, Volume: 15, Issue:1 Topics: Abortion, Induced; Adult; Antineoplastic Agents, Phytogenic; Carcinoma, Large Cell; Carcinoma, Neuroendocrine; Cervix Uteri; Etoposide; Female; Humans; Polyps; Pregnancy; Pregnancy Complications, Neoplastic; Treatment Outcome; Uterine Cervical Neoplasms	2009
Isothiocyanates sensitize the effect of chemotherapeutic drugs via modulation of protein kinase C and telomerase in cervical cancer cells. Molecular and cellular biochemistry, 2009, Volume: 330, Issue:1-2 Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Doxorubicin; Drug Synergism; Etoposide; Female; Gene Expression Regulation, Enzymologic; HeLa Cells; Humans; Isothiocyanates; Protein Kinase C; Telomerase; Uterine Cervical Neoplasms	2009
[Mullerian adenosarcoma of the uterus: A clinicopathologic analysis of 9 cases]. Zhonghua zhong liu za zhi [Chinese journal of oncology], 2010, Volume: 32, Issue:1 Topics: Adenosarcoma; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Endometrial Neoplasms; Etoposide; Female; Follow-Up Studies; Humans; Hysterectomy; Ifosfamide; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Retrospective Studies; Uterine Cervical Neoplasms; Uterine Neoplasms; Young Adult	2010
Human papillomavirus E1 and E2 mediated DNA replication is not arrested by DNA damage signalling. Virology, 2010, Oct-10, Volume: 406, Issue:1 Topics: Antigens, Viral, Tumor; Cell Line; DNA Breaks, Double-Stranded; DNA Damage; DNA Replication; DNA-Binding Proteins; DNA, Viral; Etoposide; Female; Genomic Instability; Human papillomavirus 11; Humans; Papillomaviridae; Papillomavirus Infections; Signal Transduction; Uterine Cervical Neoplasms; Viral Proteins; Virus Integration; Virus Replication	2010
Presentation of a patient with pT2bN1M0 small cell carcinoma of the uterine cervix who obtained long-term survival with maintenance chemotherapy, and literature-based discussion. European journal of gynaecological oncology, 2011, Volume: 32, Issue:1 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Etoposide; Female; Humans; Neoplasm Staging; Uterine Cervical Neoplasms	2011
Evaluation of oral etoposide in combination with cisplatin for patients with recurrent cervical cancer: long-term follow-up results of a Japanese multicenter study. Anticancer research, 2011, Volume: 31, Issue:9 Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Female; Humans; Japan; Middle Aged; Recurrence; Uterine Cervical Neoplasms	2011
Cisplatinum combined with etoposide. Effective therapy for metastasised squamous-cell carcinoma of the cervix. European journal of gynaecological oncology, 2011, Volume: 32, Issue:6 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Etoposide; Female; Humans; Middle Aged; Neoplasm Metastasis; Uterine Cervical Neoplasms	2011
Uterine cervical malignant granular cell tumor. The journal of obstetrics and gynaecology research, 2012, Volume: 38, Issue:6 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cervix Uteri; Cisplatin; Etoposide; Female; Granular Cell Tumor; Humans; Ifosfamide; Incidental Findings; Neoadjuvant Therapy; Treatment Outcome; Uterine Cervical Neoplasms	2012
Small cell neuroendocrine carcinoma of the cervix: analysis of the prognosis and role of radiation therapy for 43 cases. European journal of gynaecological oncology, 2012, Volume: 33, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carcinoma, Neuroendocrine; Chemoradiotherapy, Adjuvant; Chemotherapy, Adjuvant; Cisplatin; Etoposide; Female; Follow-Up Studies; Humans; Hysterectomy; Kaplan-Meier Estimate; Lung Neoplasms; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Prognosis; Radiotherapy, Adjuvant; Retrospective Studies; Time Factors; Uterine Cervical Neoplasms	2012
Role-shifting PKCζ fosters its own proapoptotic destruction by complexing with Bcl10 at the nuclear envelope of human cervical carcinoma cells: a proteomic and biochemical study. Journal of proteome research, 2012, Aug-03, Volume: 11, Issue:8 Topics: Adaptor Proteins, Signal Transducing; Antineoplastic Agents, Phytogenic; Apoptosis; B-Cell CLL-Lymphoma 10 Protein; Caspase 3; Cell Line, Tumor; Etoposide; Female; Gene Knockdown Techniques; Humans; Immunoprecipitation; Nuclear Envelope; Phosphorylation; Protein Binding; Protein Interaction Mapping; Protein Kinase C; Protein Processing, Post-Translational; Proteome; Proteomics; RNA Interference; Uterine Cervical Neoplasms	2012
The ubiquitin-conjugating enzyme E2-EPF is overexpressed in cervical cancer and associates with tumor growth. Oncology reports, 2012, Volume: 28, Issue:4 Topics: Animals; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Doxorubicin; Etoposide; Female; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Mice; Mice, Nude; Paclitaxel; Promoter Regions, Genetic; Reference Values; RNA, Small Interfering; Topoisomerase I Inhibitors; Topoisomerase Inhibitors; Topotecan; Ubiquitin-Conjugating Enzymes; Uterine Cervical Neoplasms	2012
Small-cell carcinoma of the cervix: fourteen years of experience at a single institution using a combined-modality regimen of involved-field irradiation and platinum-based combination chemotherapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2003, Sep-15, Volume: 21, Issue:18 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Etoposide; Female; Humans; Middle Aged; Paclitaxel; Radiotherapy Dosage; Survival Rate; Uterine Cervical Neoplasms	2003
[On pre-irradiation of the parametrium in operable cervical carcinoma with moving beam irradiation]. Radiobiologia, radiotherapia, 1963, Volume: 4 Topics: Carmustine; Etoposide; Female; Humans; Mesentery; Pelvic Floor; Radiotherapy; Uterine Cervical Neoplasms	1963
A young woman with clear cell adenocarcinoma of the uterine cervix. International journal of clinical oncology, 2003, Volume: 8, Issue:6 Topics: Adenocarcinoma, Clear Cell; Adolescent; Age of Onset; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinogens; Diethylstilbestrol; Etoposide; Female; Humans; Hysterectomy; Japan; Lymph Node Excision; Mitomycin; Neoadjuvant Therapy; Netherlands; Prognosis; Uterine Cervical Neoplasms	2003
[Metastatic cancer in transposed ovaries after radical Wertheim-Meigs hysterectomy for a stage I B and II A cervical cancer]. Akusherstvo i ginekologiia, 2003, Volume: 42, Issue:5 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Adenosquamous; Cisplatin; Etoposide; Female; Humans; Hysterectomy; Mitomycin; Neoplasm Staging; Ovarian Neoplasms; Ovary; Treatment Outcome; Uterine Cervical Neoplasms	2003
A pilot study of neoadjuvant chemotherapy with mitomycin C, etoposide, cisplatin, and epirubicin for adenocarcinoma of the cervix. International journal of clinical oncology, 2004, Volume: 9, Issue:1 Topics: Adenocarcinoma; Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Adenosquamous; Chemotherapy, Adjuvant; Cisplatin; Dose-Response Relationship, Drug; Epirubicin; Etoposide; Female; Follow-Up Studies; Humans; Hysterectomy; Lymphatic Metastasis; Middle Aged; Mitomycin; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Pilot Projects; Radiotherapy, Adjuvant; Statistics as Topic; Treatment Outcome; Uterine Cervical Neoplasms; Women's Health	2004
Response of early stage bulky cervical squamous carcinoma to preoperative adjuvant chemotherapy. Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih, 2004, Volume: 19, Issue:2 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Drug Administration Schedule; Etoposide; Female; Humans; Hysterectomy; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Preoperative Care; Uterine Cervical Neoplasms; Vincristine	2004
Phosphorylated histone H2AX in spheroids, tumors, and tissues of mice exposed to etoposide and 3-amino-1,2,4-benzotriazine-1,3-dioxide. Cancer research, 2004, Aug-01, Volume: 64, Issue:15 Topics: Animals; Antineoplastic Agents; Cell Survival; DNA Damage; Etoposide; Female; Flow Cytometry; Histones; Humans; Hypoxia; Kidney; Mice; Mice, Inbred NOD; Mice, SCID; Phosphorylation; Spheroids, Cellular; Spleen; Tirapazamine; Transplantation, Heterologous; Triazines; Tumor Stem Cell Assay; Uterine Cervical Neoplasms	2004
High-grade neuroendocrine carcinoma of the cervix. A case report. Gynecologic and obstetric investigation, 2005, Volume: 59, Issue:4 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Neuroendocrine; Cisplatin; Combined Modality Therapy; Etoposide; Female; Gynecologic Surgical Procedures; Humans; Neoplasm Staging; Radiotherapy, Adjuvant; Treatment Outcome; Uterine Cervical Neoplasms	2005
Polyadenylate polymerase modulations in human epithelioid cervix and breast cancer cell lines, treated with etoposide or cordycepin, follow cell cycle rather than apoptosis induction. Biological chemistry, 2005, Volume: 386, Issue:5 Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Caspase 6; Caspases; Cell Cycle; Cell Line, Tumor; Deoxyadenosines; DNA Fragmentation; Etoposide; Female; Humans; Isoenzymes; Neoplasms, Glandular and Epithelial; Polynucleotide Adenylyltransferase; Time Factors; Uterine Cervical Neoplasms	2005
Optimal combination chemotherapy and chemoradiotherapy with etoposide for advanced cervical squamous cancer cells in vitro. Oncology reports, 2006, Volume: 15, Issue:4 Topics: Antigens, CD20; Antineoplastic Agents, Phytogenic; Camptothecin; Carcinoma, Squamous Cell; CD40 Antigens; Cell Survival; Clone Cells; Combined Modality Therapy; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Drug Resistance, Neoplasm; Etoposide; Female; Flow Cytometry; Fluorouracil; Humans; Integrin alpha1; Integrin alpha6; Irinotecan; Mitomycin; Uterine Cervical Neoplasms; X-Rays	2006
hTERT: a novel endogenous inhibitor of the mitochondrial cell death pathway. Oncogene, 2006, Aug-03, Volume: 25, Issue:33 Topics: Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Catalytic Domain; Cell Line, Tumor; Cell Survival; Cisplatin; Colonic Neoplasms; DNA-Binding Proteins; Etoposide; fas Receptor; Female; Humans; Mitochondria; Mitomycin; Reactive Oxygen Species; Telomerase; Uterine Cervical Neoplasms	2006
[Predictive value of in vitro MTT assay chemosensitivity test of cytotoxic drug activity in cervical cancer]. Ai zheng = Aizheng = Chinese journal of cancer, 2007, Volume: 26, Issue:4 Topics: Adult; Antineoplastic Agents; Bleomycin; Carboplatin; Carcinoma, Squamous Cell; Cell Survival; Cells, Cultured; Cisplatin; Cyclophosphamide; Drug Screening Assays, Antitumor; Etoposide; Female; Fluorouracil; Humans; Middle Aged; Neoplasm Staging; Paclitaxel; Uterine Cervical Neoplasms	2007
Caspase-independent autophagic cytotoxicity in etoposide-treated CaSki cervical carcinoma cells. DNA and cell biology, 2007, Volume: 26, Issue:10 Topics: Adenine; Amino Acid Chloromethyl Ketones; Antineoplastic Agents, Phytogenic; Apoptosis; Apoptosis Regulatory Proteins; Autophagy; Beclin-1; Caspase Inhibitors; Caspases; Cell Line, Tumor; Etoposide; Female; Humans; Macrolides; Membrane Proteins; Uterine Cervical Neoplasms	2007
Phase II trial of etoposide in the management of advanced or recurrent non-squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study. Cancer treatment reports, 1984, Volume: 68, Issue:12 Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Squamous Cell; Drug Evaluation; Etoposide; Female; Humans; Middle Aged; Podophyllotoxin; Uterine Cervical Neoplasms	1984
DNA strand breakage and DNA structure influence staining with propidium iodide using the alkaline comet assay. Cytometry, 1994, Aug-01, Volume: 16, Issue:4 Topics: Alkalies; Animals; Bisbenzimidazole; Cell Line; Cricetinae; Cricetulus; DNA Damage; DNA, Single-Stranded; Electrophoresis, Agar Gel; Etoposide; Female; Fibroblasts; Humans; Hydrogen Peroxide; Hydrogen-Ion Concentration; Indoles; Lung; Male; Methylnitronitrosoguanidine; Microscopy, Fluorescence; Nucleic Acid Conformation; Nucleic Acid Denaturation; Propidium; Staining and Labeling; Tumor Cells, Cultured; Uterine Cervical Neoplasms	1994
[Experimental and clinical study on chemotherapy for cervical adenocarcinoma]. Nihon Sanka Fujinka Gakkai zasshi, 1995, Volume: 47, Issue:4 Topics: Aclarubicin; Adenocarcinoma; Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Dactinomycin; Drug Administration Schedule; Etoposide; Female; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Middle Aged; Mitomycin; Neoplasm Transplantation; Uterine Cervical Neoplasms	1995
[A case report: complete remission of stage IV uterine cervix carcinoma by immuno-chemotherapy with intraarterial infusion using implantable reservoir system]. Gan to kagaku ryoho. Cancer & chemotherapy, 1995, Volume: 22, Issue:11 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Hysterectomy; Immunotherapy; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Lymph Node Excision; Picibanil; Remission Induction; Tegafur; Uracil; Uterine Cervical Neoplasms	1995
[Simultaneous radiochemotherapy in locally advanced cancers of the cervix: a preliminary study]. Bulletin du cancer, 1995, Volume: 82, Issue:5 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Etoposide; Female; Fluorouracil; Humans; Middle Aged; Neoplasm Staging; Radiotherapy Dosage; Survival Rate; Treatment Outcome; Uterine Cervical Neoplasms	1995
Effects of single and combined application of anti-cancer drugs on cervical adenocarcinoma. I. Antitumor activity in vitro. Acta obstetricia et gynecologica Scandinavica, 1995, Volume: 74, Issue:5 Topics: Adenocarcinoma; Adult; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line; Combined Modality Therapy; Etoposide; Female; Humans; In Vitro Techniques; Interferon-gamma; Mice; Mice, Nude; Middle Aged; Mitomycin; Neoplasms, Experimental; Recombinant Proteins; Uterine Cervical Neoplasms	1995
Potentiation of tumour necrosis factor-mediated cell killing by VP16 on human ovarian cancer cell lines. In vitro results and clinical implications. European journal of cancer (Oxford, England : 1990), 1993, Volume: 29A, Issue:8 Topics: Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Drug Synergism; Etoposide; Female; Humans; Ovarian Neoplasms; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha; Tumor Stem Cell Assay; Uterine Cervical Neoplasms	1993
High complete response rate of concomitant chemoradiotherapy for locally advanced squamous cell carcinoma of the uterine cervix. Gynecologic oncology, 1996, Volume: 61, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brachytherapy; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Dose-Response Relationship, Radiation; Etoposide; Female; Fluorouracil; Humans; Middle Aged; Neoplasm Staging; Radiation Injuries; Survival Analysis; Treatment Outcome; Uterine Cervical Neoplasms	1996
Absence of correlation between chemo- and radioresistance in a range of human tumour cell lines. Cytotechnology, 1996, Volume: 19, Issue:3 Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Carcinoma; Carcinoma, Squamous Cell; Cell Division; Cisplatin; Clone Cells; Cricetinae; Cricetulus; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Etoposide; Female; HeLa Cells; Humans; Laryngeal Neoplasms; Lung Neoplasms; Neoplasms; Ovarian Neoplasms; Radiation Tolerance; Selection, Genetic; Tumor Cells, Cultured; Uterine Cervical Neoplasms; Vincristine	1996
[Two cases of adenosquamous cell carcinoma of advanced cervical cancer treated by carboplatin-based chemotherapy with peripheral blood stem cell autotransplant]. Gan to kagaku ryoho. Cancer & chemotherapy, 1997, Volume: 24, Issue:8 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Adenosquamous; Chemotherapy, Adjuvant; Combined Modality Therapy; Drug Administration Schedule; Epirubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Middle Aged; Uterine Cervical Neoplasms	1997
Clonal analysis of cancer cells that survived anticancer drug treatment. Osaka city medical journal, 1997, Volume: 43, Issue:2 Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Camptothecin; Carcinoma, Squamous Cell; Cell Survival; Doxorubicin; Enzyme Inhibitors; Etoposide; Female; Humans; Irinotecan; Tumor Cells, Cultured; Uterine Cervical Neoplasms	1997
[CDDP-resistant early recurrent uterine cervical cancer successfully treated with low-dose oral etoposide: a case report]. Gan to kagaku ryoho. Cancer & chemotherapy, 1998, Volume: 25, Issue:6 Topics: Administration, Oral; Adult; Antineoplastic Agents, Phytogenic; Carcinoma, Squamous Cell; Cisplatin; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Lymphatic Metastasis; Neoplasm Recurrence, Local; Remission Induction; Uterine Cervical Neoplasms	1998
Neoadjuvant chemotherapy with mitomycin C, etoposide, and cisplatin for adenocarcinoma of the cervix. Gynecologic oncology, 1998, Volume: 70, Issue:2 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Adenosquamous; Chemotherapy, Adjuvant; Cisplatin; Etoposide; Female; Humans; Middle Aged; Mitomycin; Neoplasm Staging; Uterine Cervical Neoplasms	1998
Rapid progression of squamous cell carcinoma of the cervix after hyperbaric oxygenation. European journal of obstetrics, gynecology, and reproductive biology, 1999, Volume: 82, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bleomycin; Carcinoma, Squamous Cell; Cisplatin; Etoposide; Fatal Outcome; Female; Humans; Hyperbaric Oxygenation; Lymph Node Excision; Lymphatic Diseases; Magnetic Resonance Imaging; Middle Aged; Neoplasm Recurrence, Local; Tomography, X-Ray Computed; Uterine Cervical Neoplasms	1999
Small cell carcinoma of the cervix complicated by pregnancy. Clinical oncology (Royal College of Radiologists (Great Britain)), 1999, Volume: 11, Issue:2 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Diagnosis, Differential; Etoposide; Female; Humans; Pregnancy; Pregnancy Complications, Neoplastic; Remission Induction; Uterine Cervical Neoplasms	1999
Metastatic carcinoma in a transposed ovary after radical hysterectomy for a stage 1B cervical adenosquamous cell carcinoma. Case report. European journal of gynaecological oncology, 2000, Volume: 21, Issue:4 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Adenosquamous; Cisplatin; Etoposide; Female; Humans; Hysterectomy; Mitomycin; Ovarian Neoplasms; Ovariectomy; Ovary; Uterine Cervical Neoplasms	2000
Changes in subcellular distribution of topoisomerase IIalpha correlate with etoposide resistance in multicell spheroids and xenograft tumors. Cancer research, 2000, Oct-15, Volume: 60, Issue:20 Topics: Animals; Antigens, Neoplasm; Antineoplastic Agents, Phytogenic; Colonic Neoplasms; Cricetinae; Cricetulus; DNA Topoisomerases, Type II; DNA-Binding Proteins; Drug Resistance, Neoplasm; Etoposide; Female; Fibroblasts; Glioma; Humans; Isoenzymes; Mice; Mice, Inbred NOD; Mice, SCID; Spheroids, Cellular; Subcellular Fractions; Tumor Cells, Cultured; Uterine Cervical Neoplasms; Xenograft Model Antitumor Assays	2000
Anti-neoplastic activity of topotecan versus cisplatin, etoposide and paclitaxel in four squamous cell cancer cell lines of the female genital tract using an ATP-Tumor Chemosensitivity Assay. Anti-cancer drugs, 2000, Volume: 11, Issue:10 Topics: Adenosine Triphosphate; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Etoposide; Female; Humans; Luminescent Measurements; Paclitaxel; Topotecan; Tumor Cells, Cultured; Uterine Cervical Neoplasms; Vulvar Neoplasms	2000
Primary high-grade mucosa-associated lymphoid tissue-type lymphoma of the cervix presenting as a common endocervical polyp. Archives of pathology & laboratory medicine, 2001, Volume: 125, Issue:4 Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Cyclophosphamide; Cytarabine; Diagnosis, Differential; Epirubicin; Etoposide; Female; Humans; Hysterectomy; Immunohistochemistry; In Situ Hybridization; Lymphoma, B-Cell, Marginal Zone; Methotrexate; Middle Aged; Neoplasm Proteins; Polyps; Prednisone; Uterine Cervical Neoplasms; Vincristine	2001
Vitamin C augments chemotherapeutic response of cervical carcinoma HeLa cells by stabilizing P53. Biochemical and biophysical research communications, 2001, Mar-30, Volume: 282, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Ascorbic Acid; bcl-2-Associated X Protein; Cell Cycle; Cisplatin; Down-Regulation; Drug Stability; Drug Synergism; Etoposide; Female; HeLa Cells; Humans; Oncogene Proteins, Viral; Papillomaviridae; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Telomerase; Transcription, Genetic; Tumor Suppressor Protein p53; Uterine Cervical Neoplasms	2001
Locally advanced cervix cancer: chemotherapy prior to definitive surgery or radiotherapy. A single institutional experience. Australasian radiology, 2001, Volume: 45, Issue:4 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Epirubicin; Etoposide; Female; Humans; Middle Aged; Multivariate Analysis; Neoadjuvant Therapy; Retrospective Studies; Survival Analysis; Treatment Outcome; Uterine Cervical Neoplasms	2001
Chemotherapy as initial treatment for cervical carcinoma: clinical and tumor marker response. Acta obstetricia et gynecologica Scandinavica, 1992, Volume: 71, Issue:4 Topics: Adenocarcinoma; Antigens, Neoplasm; Antigens, Tumor-Associated, Carbohydrate; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoembryonic Antigen; Carcinoma, Squamous Cell; Cisplatin; Cyclophosphamide; Epirubicin; Etoposide; Female; Humans; Middle Aged; Serpins; Trypsin Inhibitor, Kazal Pancreatic; Uterine Cervical Neoplasms	1992
Cardiac tamponade resulting from recurrent small-cell carcinoma of the uterine cervix temporarily responding to CE/CAV chemotherapy: report of a case. Journal of the Formosan Medical Association = Taiwan yi zhi, 1992, Volume: 91, Issue:8 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cardiac Tamponade; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Neoplasm Recurrence, Local; Uterine Cervical Neoplasms; Vincristine	1992
[Characterization of two novel cell lines established from a single human uterine cervical adenocarcinoma, and their chemosensitivities and hormonal effects on their proliferation]. Nihon Sanka Fujinka Gakkai zasshi, 1992, Volume: 44, Issue:4 Topics: Adenocarcinoma; Animals; Carbazilquinone; Cell Division; Drug Screening Assays, Antitumor; Estradiol; Etoposide; Female; Humans; Methotrexate; Mice; Mitomycin; Neoplasm Transplantation; Progesterone; Tumor Cells, Cultured; Uterine Cervical Neoplasms	1992
Etoposide (VP-16), ifosfamide/mesna, and cisplatin chemotherapy for advanced and recurrent carcinoma of the cervix. Gynecologic oncology, 1991, Volume: 43, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Etoposide; Female; Hematologic Diseases; Humans; Ifosfamide; Mesna; Middle Aged; Neoplasm Recurrence, Local; Uterine Cervical Neoplasms	1991
[In vitro combined effects of pirarubicin (THP) and various antitumor drugs on human tumor cell lines]. Gan to kagaku ryoho. Cancer & chemotherapy, 1990, Volume: 17, Issue:4 Pt 1 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Doxorubicin; Drug Screening Assays, Antitumor; Drug Synergism; Etoposide; Female; Humans; Leukemia, Myeloid; Methotrexate; Mitomycin; Mitomycins; Tumor Cells, Cultured; Uterine Cervical Neoplasms	1990
Squamous cell carcinoma antigen and carcinoembryonic antigen levels as prognostic factors for the response of cervical carcinoma to chemotherapy. Gynecologic oncology, 1990, Volume: 38, Issue:1 Topics: Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carboplatin; Carcinoembryonic Antigen; Cisplatin; Etoposide; Female; Humans; Ifosfamide; Neoplasm Metastasis; Organoplatinum Compounds; Prognosis; Recurrence; Serpins; Uterine Cervical Neoplasms	1990
Chemotherapy-radiation interactions in human cervix carcinoma xenografts. British journal of cancer, 1988, Volume: 58, Issue:6 Topics: Animals; Bleomycin; Brachytherapy; Cell Line; Cisplatin; Combined Modality Therapy; Etoposide; Female; Humans; Ifosfamide; Mice; Mice, Nude; Neoplasm Transplantation; Radiotherapy Dosage; Transplantation, Heterologous; Uterine Cervical Neoplasms	1988
In vitro chemosensitivity of four new carcinoma of the cervix cell lines: relationship to radiosensitivity. European journal of cancer & clinical oncology, 1989, Volume: 25, Issue:8 Topics: Antineoplastic Agents; Bleomycin; Cell Line; Cisplatin; Drug Tolerance; Etoposide; Female; Humans; Methotrexate; Radiation Tolerance; Tumor Cells, Cultured; Tumor Stem Cell Assay; Uterine Cervical Neoplasms	1989
Cytotoxicity mediated by tumor necrosis factor in variant subclones of the ME-180 cervical carcinoma line: modulation by specific inhibitors of DNA topoisomerase II. Journal of cellular biochemistry, 1989, Volume: 39, Issue:2 Topics: Cell Communication; Cell Survival; DNA Topoisomerases, Type II; Drug Synergism; Etoposide; Female; Kinetics; Lymphotoxin-alpha; Mitomycin; Mitomycins; Teniposide; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha; Uterine Cervical Neoplasms	1989
[The course of squamous cell carcinoma antigen and CEA as prognostic criteria for response to chemotherapy in cervix cancer]. Geburtshilfe und Frauenheilkunde, 1989, Volume: 49, Issue:12 Topics: Adenocarcinoma; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carboplatin; Carcinoembryonic Antigen; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Etoposide; Female; Humans; Ifosfamide; Neoplasm Recurrence, Local; Organoplatinum Compounds; Prognosis; Serpins; Uterine Cervical Neoplasms	1989
[A case of recurrent uterine cervical cancer successfully treated with etoposide]. Gan to kagaku ryoho. Cancer & chemotherapy, 1989, Volume: 16, Issue:9 Topics: Administration, Oral; Aged; Drug Administration Schedule; Etoposide; Female; Humans; Neoplasm Recurrence, Local; Prognosis; Uterine Cervical Neoplasms	1989
[Sensitivity to etoposide in cultured cells from cervical squamous cell carcinoma]. Nihon Sanka Fujinka Gakkai zasshi, 1986, Volume: 38, Issue:11 Topics: Carcinoma, Squamous Cell; Cell Division; Cells, Cultured; Drug Resistance; Etoposide; Female; Humans; Kinetics; Uterine Cervical Neoplasms	1986
Predictive testing of vulvar and cervical cancers to chemotherapy by the subrenal capsule assay. European journal of cancer & clinical oncology, 1985, Volume: 21, Issue:10 Topics: Adult; Aged; Animals; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Resistance; Etoposide; Female; Humans; Kidney; Methotrexate; Mice; Middle Aged; Neoplasm Transplantation; Tumor Stem Cell Assay; Uterine Cervical Neoplasms; Vulvar Neoplasms	1985